[使用BMA-120单克隆抗体对睾丸鞘膜恶性间皮瘤进行初步检测]
[Primary detection of malignant mesothelioma of the tunica vaginalis testis using the BMA-120 monoclonal antibody].
作者信息
Biermann C W, Moch H, Gasser T C, de Riese W, Rutishauser G
机构信息
Urologische Universitätsklinik, Ruhr-Universität Bochum, Marienhospital Herne.
出版信息
Helv Chir Acta. 1994 Dec;60(6):1127-9.
Malignant mesothelioma of the tunica vaginalis testis is an extremely rare tumor, with only 40 cases previously described in the literature. Treatment consists of inguinal orchiectomy with close-follow up [1]. Asbestose exposure, trauma and hydrocele have been implicated as risk factors. We describe a histopathological examination with the BMA antibody (Behring, Marburg, Germany) and the Lu-5 antibody (Hoffmann-La Roche, Basel, Switzerland). Furthermore, we describe the patient's history and the management according to preceding reports in the literature.
睾丸鞘膜恶性间皮瘤是一种极其罕见的肿瘤，此前文献中仅描述过40例。治疗方法为腹股沟睾丸切除术并密切随访[1]。石棉暴露、创伤和鞘膜积液被认为是危险因素。我们描述了使用BMA抗体（德国马尔堡贝林公司）和Lu-5抗体（瑞士巴塞尔霍夫曼-罗氏公司）进行的组织病理学检查。此外，我们还根据文献中的先前报道描述了该患者的病史及治疗情况。
Zotero 插件